<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22137" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Genetics, Epigenetic Mechanism</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Al Aboud</surname>
            <given-names>Nora M.</given-names>
          </name>
          <aff>Umm Al-Qura University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tupper</surname>
            <given-names>Connor</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jialal</surname>
            <given-names>Ishwarlal</given-names>
          </name>
          <aff>VA MEDICAL CENTER, MATHER , CA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nora Al Aboud declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Connor Tupper declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ishwarlal Jialal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22137.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Epigenetics is the study of heritable and stable changes in gene expression that occur through alterations in the chromosome rather than in the DNA sequence.&#x000a0;<xref ref-type="bibr" rid="article-22137.r1">[1]</xref> Despite not directly altering the DNA sequence, epigenetic mechanisms can regulate gene expression through chemical modifications of DNA bases and changes to the chromosomal superstructure in which DNA is packaged.</p>
        <p>Briefly, negatively charged DNA is packaged around a positively charged histone protein octamer, which contains 2 copies of histone proteins H2A, H2B, H3, and H4.&#x000a0;<xref ref-type="bibr" rid="article-22137.r2">[2]</xref> This nucleoprotein complex is a nucleosome, the basic unit of chromatin.&#x000a0;<xref ref-type="bibr" rid="article-22137.r3">[3]</xref> The nucleosomes of a continuous DNA polymer are connected by linker DNA and the complex is stabilized by histone protein H1. The aggregation of chromatin results in the formation of a chromosome. The chromatin of a chromosome exists as either loose, transcriptionally active euchromatin or dense, transcriptionally inactive heterochromatin.&#x000a0;<xref ref-type="bibr" rid="article-22137.r4">[4]</xref> Chemical alterations to histone proteins can induce the formation of either the open euchromatin state, which facilitates gene expression by allowing transcription factors and enzymes to interact with the DNA, or the closed heterochromatin state, which suppresses gene expression by preventing initiation of transcription.</p>
        <p>In addition to histone changes, DNA methylation is an epigenetic mechanism associated with gene silencing when the methylation occurs in CpG islands of promoter sequences.&#x000a0;<xref ref-type="bibr" rid="article-22137.r5">[5]</xref> Further, non-coding RNA sequences have shown to play a key role in the regulation of gene expression.&#x000a0;<xref ref-type="bibr" rid="article-22137.r6">[6]</xref> These epigenetic modifications can be induced by several factors including age, diet, smoking, stress, and disease state.&#x000a0;<xref ref-type="bibr" rid="article-22137.r7">[7]</xref><xref ref-type="bibr" rid="article-22137.r8">[8]</xref> Epigenetic modifications are reversible, but they rarely remain through generations in humans despite persisting through multiple cycles of cell replication.&#x000a0;<xref ref-type="bibr" rid="article-22137.r9">[9]</xref></p>
      </sec>
      <sec id="article-22137.s2" sec-type="Cellular">
        <title>Cellular</title>
        <p>Epigenetic mechanisms form a layer of control within a cell that regulates gene expression and silencing. This control varies between tissues and plays an important role in cell differentiation.&#x000a0;<xref ref-type="bibr" rid="article-22137.r10">[10]</xref> Additionally, differences in gene expression between cells, which are driven by epigenetic modifications, result in the unique function of specific cell types.&#x000a0;<xref ref-type="bibr" rid="article-22137.r11">[11]</xref> Genome-wide patterns of DNA and histone modifications are established during early development and are maintained throughout multiple cell divisions. In cancer, the normal epigenetic patterns are disrupted resulting in the expression of anti-apoptotic and pro-proliferative genes and silencing of tumor suppressor genes like CDKN2A.&#x000a0;<xref ref-type="bibr" rid="article-22137.r12">[12]</xref></p>
        <p>Three different epigenetic mechanisms have been identified: DNA methylation, histone modification, and non-coding RNA (ncRNA)-associated gene silencing. Catalyzed by DNA methyltransferase enzymes, DNA methylation involves the addition of a methyl group directly to a cytosine nucleotide within a cytosine-guanine sequence (CpG), which are often surrounded by other CpG&#x02019;s forming a CpG island. CpG islands are common targets for epigenetic DNA methylation, notably the CpG islands within promoter regions. Indeed, it has been reported that around 70% of gene promotor regions lie within CpG islands.&#x000a0;<xref ref-type="bibr" rid="article-22137.r13">[13]</xref> Methylated cytosines within a promoter region recruit gene suppressor proteins and reduce interaction between the DNA and transcription factors.&#x000a0;<xref ref-type="bibr" rid="article-22137.r14">[14]</xref> Cytosine methylation also drives the formation of heterochromatin, so the nucleosome tightening prevents transcriptional machinery from interacting with the DNA.&#x000a0;<xref ref-type="bibr" rid="article-22137.r15">[15]</xref> As such, DNA methylation within promoter regions results in gene silencing. Cancers often show marked hypermethylation of tumor suppressor genes and hypomethylation of proto-oncogenes, both of which contribute to tumor carcinogenesis.&#x000a0;<xref ref-type="bibr" rid="article-22137.r15">[15]</xref> This epigenetic mechanism also plays an important role in tissue-specific gene regulation, genomic imprinting, and X chromosome inactivation.&#x000a0;<xref ref-type="bibr" rid="article-22137.r14">[14]</xref></p>
        <p>The second epigenetic mechanism is post-translational modifications to histone proteins. These modifications include enzyme-catalyzed acetylation, methylation, phosphorylation, and ubiquitylation, each of which alters the DNA-histone interactions in nucleosomes.&#x000a0;<xref ref-type="bibr" rid="article-22137.r16">[16]</xref> Histone acetylation often occurs at positively charged lysine residues which weakens the DNA-histone interactions, thus opening the chromatin and facilitating transcription.&#x000a0;<xref ref-type="bibr" rid="article-22137.r17">[17]</xref> For example, acetylation of lysine 9 and lysine 27 on histone 3 (H3K9ac and H3K27ac, respectively) correlates with transcription activation. Histone methylation is more complex as it does not change the histone protein charge and can include the addition of 1-3 methyl groups to lysine and 1-2 methyl groups to arginine.&#x000a0;<xref ref-type="bibr" rid="article-22137.r17">[17]</xref> For example, methylation of lysine 4 on histone 3 (H3K4me) is associated with transcription activation while trimethylation of lysine 27 on histone 3 (H3K27me3) correlates with transcription repression.&#x000a0;<xref ref-type="bibr" rid="article-22137.r18">[18]</xref> Histone phosphorylation involves the addition of a negative phosphate group to the histone tail, but less is known of its function aside from phosphorylation of H2A(X) playing a role in the response to DNA damage and its subsequent repair.&#x000a0;<xref ref-type="bibr" rid="article-22137.r19">[19]</xref> Histone ubiquitylation involves the addition of a large ubiquitin molecule to lysine residues. Examples of histone ubiquitylation include H2AK119ub, which is associated with gene silencing, and H2BK123ub, which is involved in transcription.&#x000a0;<xref ref-type="bibr" rid="article-22137.r17">[17]</xref> Aside from the relatively straightforward effect of histone acetylation on gene expression, the effects of other histone modifications are complex and greatly influenced by the state of nearby DNA molecules.</p>
        <p>The most recently elucidated epigenetic mechanism is non-coding RNA-associated gene silencing. A non-coding RNA (ncRNA) is a functional RNA molecule that is transcribed but not translated into proteins. Once regarded as waste of the genome, recent insight suggests the ncRNA molecules harbor a crucial role in epigenetic gene expression and likely account for the great difference in phenotype between species and within human populations despite such similarity in encoded proteins.&#x000a0;<xref ref-type="bibr" rid="article-22137.r6">[6]</xref><xref ref-type="bibr" rid="article-22137.r18">[18]</xref> Notable ncRNA molecules include microRNAs (miRNA) and short interfering RNAs (siRNA), which include less than 30 nucleotides, and long non-coding RNAs (lncRNA), which are 200 nucleotides or longer. Though the full extent of their role in epigenetics is still being determined, there is evidence suggesting that ncRNAs participate in DNA methylation and histone modifications in addition to gene silencing.&#x000a0;<xref ref-type="bibr" rid="article-22137.r20">[20]</xref> siRNAs and lncRNAs both have been shown to regulate gene expression by the formation of heterochromatin.&#x000a0;<xref ref-type="bibr" rid="article-22137.r6">[6]</xref><xref ref-type="bibr" rid="article-22137.r21">[21]</xref></p>
      </sec>
      <sec id="article-22137.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>As people age, the largest influence on the epigenome is the environment. Direct influencers such as diet can affect one's epigenome, as determined by the Dutch famine studies.&#x000a0;<xref ref-type="bibr" rid="article-22137.r22">[22]</xref><xref ref-type="bibr" rid="article-22137.r23">[23]</xref> Other environmental stressors include smoking and psychological stress. Epigenetic changes <italic toggle="yes">in utero</italic> are particularly sensitive as the epigenetic profile of the fetus is forming and developing rapidly during this time.&#x000a0;<xref ref-type="bibr" rid="article-22137.r24">[24]</xref> Indeed, teratogens like cigarette smoke, alcohol, and specific minerals have shown to induce <italic toggle="yes">in utero</italic> epigenetic changes.&#x000a0;<xref ref-type="bibr" rid="article-22137.r24">[24]</xref><xref ref-type="bibr" rid="article-22137.r25">[25]</xref></p>
        <p>Perhaps the most studied clinical application of epigenetic mechanisms is cancer. One of the first reports of epigenetics involved in cancer reported hypomethylation of DNA in cancer cell genomes, which caused overexpression of genes within that cell.&#x000a0;<xref ref-type="bibr" rid="article-22137.r26">[26]</xref> Since this report, great strides have been made toward understanding the role of epigenetics in carcinogenesis. For example, the degree of DNA methylation continues to decrease as a benign tumor cell progresses to invasive cancer.&#x000a0;<xref ref-type="bibr" rid="article-22137.r27">[27]</xref> Other studies have shown hypomethylation of pro-proliferative genes like BAX2 that are suppressed in normal cells.&#x000a0;<xref ref-type="bibr" rid="article-22137.r28">[28]</xref> Other reports show hypermethylation of tumor suppressor genes, like Rb, BCRA1, and CDKN2A, in cancer cells.&#x000a0;<xref ref-type="bibr" rid="article-22137.r29">[29]</xref><xref ref-type="bibr" rid="article-22137.r30">[30]</xref><xref ref-type="bibr" rid="article-22137.r31">[31]</xref>&#x000a0;Despite the wealth of knowledge present on the relationship between epigenetics and carcinogenesis, treatment development is still very much in the preliminary phase for&#x000a0;most cancers.</p>
        <p>Epigenetics is a promising field of research because of the potential to regulate gene expression without changing the DNA sequence, which may likely cause safety and ethical concerns if performed in humans. The most promising way to treat diseases through epigenetic regulation has been through pharmacology. Previous clinical trials for drugs formulated to block epigenetic modifications associated with cancers have proved successful. The FDA has approved a number of these drugs which target epigenetic regulators to treat various cancers including azacytidine and decitabine for myelodysplastic syndrome, panobinostat for multiple myeloma, and romidepsin for cutaneous T cell lymphoma.&#x000a0;<xref ref-type="bibr" rid="article-22137.r32">[32]</xref> More drugs are likely to be approved in the coming years as a number of clinical trials for DNA methylation inhibitors and histone modification inhibitors are underway.</p>
        <p>In addition to cancers, many conditions associated with genomic imprinting are the result of malfunctioning epigenetic mechanisms. Epigenetic mechanisms can induce disease, but they are also necessary for normal cell function, specifically in imprinted genes where only one parental chromosome is expressed. For genomic imprinting to successfully occur, the other parental chromosome must be silenced, which occurs through DNA methylation. Noteworthy conditions associated with abnormalities in gene imprinting include Prader-Willi syndrome, Angelman syndrome, Beckwith-Wiedemann syndrome, Russell-Silver syndrome, and Rubenstein-Taybi syndrome.&#x000a0;<xref ref-type="bibr" rid="article-22137.r33">[33]</xref><xref ref-type="bibr" rid="article-22137.r34">[34]</xref> Recent studies have shown positive results for epigenetic-based therapies for imprinting disorders, which may be a field of increased focus in the coming years in search of better treatments.&#x000a0;<xref ref-type="bibr" rid="article-22137.r35">[35]</xref><xref ref-type="bibr" rid="article-22137.r36">[36]</xref></p>
      </sec>
      <sec id="article-22137.s4">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22137&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22137">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22137/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22137">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-22137.s5">
        <title>References</title>
        <ref id="article-22137.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berger</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Kouzarides</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shiekhattar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shilatifard</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>An operational definition of epigenetics.</article-title>
            <source>Genes Dev</source>
            <year>2009</year>
            <month>Apr</month>
            <day>01</day>
            <volume>23</volume>
            <issue>7</issue>
            <fpage>781</fpage>
            <page-range>781-3</page-range>
            <pub-id pub-id-type="pmid">19339683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quina</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Buschbeck</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Croce</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Chromatin structure and epigenetics.</article-title>
            <source>Biochem Pharmacol</source>
            <year>2006</year>
            <month>Nov</month>
            <day>30</day>
            <volume>72</volume>
            <issue>11</issue>
            <fpage>1563</fpage>
            <page-range>1563-9</page-range>
            <pub-id pub-id-type="pmid">16836980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allis</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Jenuwein</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The molecular hallmarks of epigenetic control.</article-title>
            <source>Nat Rev Genet</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>8</issue>
            <fpage>487</fpage>
            <page-range>487-500</page-range>
            <pub-id pub-id-type="pmid">27346641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Workman</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>The role of chromatin during transcription.</article-title>
            <source>Cell</source>
            <year>2007</year>
            <month>Feb</month>
            <day>23</day>
            <volume>128</volume>
            <issue>4</issue>
            <fpage>707</fpage>
            <page-range>707-19</page-range>
            <pub-id pub-id-type="pmid">17320508</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feinberg</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>The Key Role of Epigenetics in Human Disease Prevention and Mitigation.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Apr</month>
            <day>05</day>
            <volume>378</volume>
            <issue>14</issue>
            <fpage>1323</fpage>
            <page-range>1323-1334</page-range>
            <pub-id pub-id-type="pmid">29617578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fr&#x000ed;as-Lasserre</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Villagra</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>The Importance of ncRNAs as Epigenetic Mechanisms in Phenotypic Variation and Organic Evolution.</article-title>
            <source>Front Microbiol</source>
            <year>2017</year>
            <volume>8</volume>
            <fpage>2483</fpage>
            <pub-id pub-id-type="pmid">29312192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tyler</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Epigenetics and aging.</article-title>
            <source>Sci Adv</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>2</volume>
            <issue>7</issue>
            <fpage>e1600584</fpage>
            <pub-id pub-id-type="pmid">27482540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alegr&#x000ed;a-Torres</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Baccarelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bollati</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Epigenetics and lifestyle.</article-title>
            <source>Epigenomics</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-77</page-range>
            <pub-id pub-id-type="pmid">22122337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heard</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Martienssen</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Transgenerational epigenetic inheritance: myths and mechanisms.</article-title>
            <source>Cell</source>
            <year>2014</year>
            <month>Mar</month>
            <day>27</day>
            <volume>157</volume>
            <issue>1</issue>
            <fpage>95</fpage>
            <page-range>95-109</page-range>
            <pub-id pub-id-type="pmid">24679529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atlasi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Stunnenberg</surname>
                <given-names>HG</given-names>
              </name>
            </person-group>
            <article-title>The interplay of epigenetic marks during stem cell differentiation and development.</article-title>
            <source>Nat Rev Genet</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>11</issue>
            <fpage>643</fpage>
            <page-range>643-658</page-range>
            <pub-id pub-id-type="pmid">28804139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheedipudi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Genolet</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Dobreva</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Epigenetic inheritance of cell fates during embryonic development.</article-title>
            <source>Front Genet</source>
            <year>2014</year>
            <volume>5</volume>
            <fpage>19</fpage>
            <pub-id pub-id-type="pmid">24550937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kazanets</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shorstova</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hilmi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Marques</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Witcher</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Epigenetic silencing of tumor suppressor genes: Paradigms, puzzles, and potential.</article-title>
            <source>Biochim Biophys Acta</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>1865</volume>
            <issue>2</issue>
            <fpage>275</fpage>
            <page-range>275-88</page-range>
            <pub-id pub-id-type="pmid">27085853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saxonov</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brutlag</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2006</year>
            <month>Jan</month>
            <day>31</day>
            <volume>103</volume>
            <issue>5</issue>
            <fpage>1412</fpage>
            <page-range>1412-7</page-range>
            <pub-id pub-id-type="pmid">16432200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Le</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>DNA methylation and its basic function.</article-title>
            <source>Neuropsychopharmacology</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-38</page-range>
            <pub-id pub-id-type="pmid">22781841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McMahon</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Karunasena</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ahuja</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>The Roles of DNA Methylation in the Stages of Cancer.</article-title>
            <source>Cancer J</source>
            <year>2017</year>
            <season>Sep/Oct</season>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>257</fpage>
            <page-range>257-261</page-range>
            <pub-id pub-id-type="pmid">28926425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alaskhar Alhamwe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Khalaila</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>von B&#x000fc;low</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Harb</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Alhamdan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hii</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Prescott</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Ferrante</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Renz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Garn</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Potaczek</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Histone modifications and their role in epigenetics of atopy and allergic diseases.</article-title>
            <source>Allergy Asthma Clin Immunol</source>
            <year>2018</year>
            <volume>14</volume>
            <fpage>39</fpage>
            <pub-id pub-id-type="pmid">29796022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bannister</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kouzarides</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Regulation of chromatin by histone modifications.</article-title>
            <source>Cell Res</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>381</fpage>
            <page-range>381-95</page-range>
            <pub-id pub-id-type="pmid">21321607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Esteller</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Epigenetics in cancer.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>Mar</month>
            <day>13</day>
            <volume>358</volume>
            <issue>11</issue>
            <fpage>1148</fpage>
            <page-range>1148-59</page-range>
            <pub-id pub-id-type="pmid">18337604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rossetto</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Avvakumov</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>C&#x000f4;t&#x000e9;</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Histone phosphorylation: a chromatin modification involved in diverse nuclear events.</article-title>
            <source>Epigenetics</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>10</issue>
            <fpage>1098</fpage>
            <page-range>1098-108</page-range>
            <pub-id pub-id-type="pmid">22948226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wei</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Non-coding RNAs as regulators in epigenetics (Review).</article-title>
            <source>Oncol Rep</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-9</page-range>
            <pub-id pub-id-type="pmid">27841002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chisholm</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Montgomery</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Detection of long non-coding RNA in archival tissue: correlation with polycomb protein expression in primary and metastatic breast carcinoma.</article-title>
            <source>PLoS One</source>
            <year>2012</year>
            <volume>7</volume>
            <issue>10</issue>
            <fpage>e47998</fpage>
            <pub-id pub-id-type="pmid">23133536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heijmans</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Tobi</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Putter</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Blauw</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Susser</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Slagboom</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Lumey</surname>
                <given-names>LH</given-names>
              </name>
            </person-group>
            <article-title>Persistent epigenetic differences associated with prenatal exposure to famine in humans.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2008</year>
            <month>Nov</month>
            <day>04</day>
            <volume>105</volume>
            <issue>44</issue>
            <fpage>17046</fpage>
            <page-range>17046-9</page-range>
            <pub-id pub-id-type="pmid">18955703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tobi</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Lumey</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Talens</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Kremer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Putter</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Slagboom</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Heijmans</surname>
                <given-names>BT</given-names>
              </name>
            </person-group>
            <article-title>DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific.</article-title>
            <source>Hum Mol Genet</source>
            <year>2009</year>
            <month>Nov</month>
            <day>01</day>
            <volume>18</volume>
            <issue>21</issue>
            <fpage>4046</fpage>
            <page-range>4046-53</page-range>
            <pub-id pub-id-type="pmid">19656776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marsit</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Influence of environmental exposure on human epigenetic regulation.</article-title>
            <source>J Exp Biol</source>
            <year>2015</year>
            <month>Jan</month>
            <day>01</day>
            <volume>218</volume>
            <issue>Pt 1</issue>
            <fpage>71</fpage>
            <page-range>71-9</page-range>
            <pub-id pub-id-type="pmid">25568453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murphy</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Adigun</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Overcash</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jirtle</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Schildkraut</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Murtha</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Iversen</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Hoyo</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Gender-specific methylation differences in relation to prenatal exposure to cigarette smoke.</article-title>
            <source>Gene</source>
            <year>2012</year>
            <month>Feb</month>
            <day>15</day>
            <volume>494</volume>
            <issue>1</issue>
            <fpage>36</fpage>
            <page-range>36-43</page-range>
            <pub-id pub-id-type="pmid">22202639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feinberg</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Vogelstein</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Hypomethylation distinguishes genes of some human cancers from their normal counterparts.</article-title>
            <source>Nature</source>
            <year>1983</year>
            <month>Jan</month>
            <day>06</day>
            <volume>301</volume>
            <issue>5895</issue>
            <fpage>89</fpage>
            <page-range>89-92</page-range>
            <pub-id pub-id-type="pmid">6185846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fraga</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Herranz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Espada</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ballestar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Paz</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Ropero</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Erkek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bozdogan</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Peinado</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Niveleau</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Balmain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Esteller</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors.</article-title>
            <source>Cancer Res</source>
            <year>2004</year>
            <month>Aug</month>
            <day>15</day>
            <volume>64</volume>
            <issue>16</issue>
            <fpage>5527</fpage>
            <page-range>5527-34</page-range>
            <pub-id pub-id-type="pmid">15313885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yi</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis.</article-title>
            <source>Nature</source>
            <year>2005</year>
            <month>Dec</month>
            <day>15</day>
            <volume>438</volume>
            <issue>7070</issue>
            <fpage>981</fpage>
            <page-range>981-7</page-range>
            <pub-id pub-id-type="pmid">16355216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sakai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Toguchida</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ohtani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yandell</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Rapaport</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Dryja</surname>
                <given-names>TP</given-names>
              </name>
            </person-group>
            <article-title>Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.</article-title>
            <source>Am J Hum Genet</source>
            <year>1991</year>
            <month>May</month>
            <volume>48</volume>
            <issue>5</issue>
            <fpage>880</fpage>
            <page-range>880-8</page-range>
            <pub-id pub-id-type="pmid">1673287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herman</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Baylin</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Gene silencing in cancer in association with promoter hypermethylation.</article-title>
            <source>N Engl J Med</source>
            <year>2003</year>
            <month>Nov</month>
            <day>20</day>
            <volume>349</volume>
            <issue>21</issue>
            <fpage>2042</fpage>
            <page-range>2042-54</page-range>
            <pub-id pub-id-type="pmid">14627790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liau</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Hsiao</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <article-title>Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age.</article-title>
            <source>Hum Pathol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>533</fpage>
            <page-range>533-9</page-range>
            <pub-id pub-id-type="pmid">24440092</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Mo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.</article-title>
            <source>Signal Transduct Target Ther</source>
            <year>2019</year>
            <volume>4</volume>
            <fpage>62</fpage>
            <pub-id pub-id-type="pmid">31871779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalish</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bartolomei</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Epigenetics and imprinting in human disease.</article-title>
            <source>Int J Dev Biol</source>
            <year>2014</year>
            <volume>58</volume>
            <issue>2-4</issue>
            <fpage>291</fpage>
            <page-range>291-8</page-range>
            <pub-id pub-id-type="pmid">25023695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kowall</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Epigenetic mechanisms of Rubinstein-Taybi syndrome.</article-title>
            <source>Neuromolecular Med</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>16</fpage>
            <page-range>16-24</page-range>
            <pub-id pub-id-type="pmid">24381114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>YH</given-names>
              </name>
            </person-group>
            <article-title>Epigenetic therapy of Prader-Willi syndrome.</article-title>
            <source>Transl Res</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>208</volume>
            <fpage>105</fpage>
            <page-range>105-118</page-range>
            <pub-id pub-id-type="pmid">30904443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22137.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papulino</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chianese</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Nicoletti</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Benedetti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Altucci</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Preclinical and Clinical Epigenetic-Based Reconsideration of Beckwith-Wiedemann Syndrome.</article-title>
            <source>Front Genet</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>563718</fpage>
            <pub-id pub-id-type="pmid">33101381</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
